Does REGORAFENIB Cause Off label use? 1,906 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,906 reports of Off label use have been filed in association with REGORAFENIB (Stivarga). This represents 20.2% of all adverse event reports for REGORAFENIB.
1,906
Reports of Off label use with REGORAFENIB
20.2%
of all REGORAFENIB reports
244
Deaths
702
Hospitalizations
How Dangerous Is Off label use From REGORAFENIB?
Of the 1,906 reports, 244 (12.8%) resulted in death, 702 (36.8%) required hospitalization, and 34 (1.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 1,906 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
Pyrexia (626)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which REGORAFENIB Alternatives Have Lower Off label use Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR